Bearing in mind the increased expression of HYAL-2, protecting the endothelial glycocalyx from HA shedding, an increasingly recognized goal in the management of sepsis and diabetes mellitus52,53, may warrant attention in patients with COPD as well. The gene discussed is HYAL2; the disease is chronic obstructive pulmonary disease.